Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Smart packaging key to complex regulatory and consumer informational systems, says GlobalData

FMCG product packaging is at the core of a growing informational system, encompassing regulators, packaging producers, their clients, and consumers. Through the ongoing evolution and roll-out of new forms of smart packaging, its overall impact is increasing beyond the boundaries of a simple product container, says GlobalData, a leading intelligence and productivity platform. With regulatory […]
Read more

BSNL’s satellite handset launch to elevate India’s always-connected future, says GlobalData

BSNL’s launch of a dedicated satellite handset marks a significant milestone in India’s efforts to ensure ubiquitous and resilient communications. Priced at INR134,166 ($1,406.59) inclusive of taxes, the device is designed to deliver voice and SMS connectivity in locations beyond the reach of terrestrial mobile networks, underscoring its role as a specialized communications tool rather […]
Read more

Diagnosed prevalent cases of overweight and obesity across 7MM to reach over 260 million in 2035, forecasts GlobalData

The diagnosed prevalent cases of overweight and obesity combined in the seven major markets (7MM*) are set to increase at an annual growth rate (AGR) of 0.61%, from over 245 million in 2025 to 260 million in 2035, forecasts GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Overweight and Obesity: Epidemiology Report and […]
Read more

GlobalData integrates its AI Research Analyst into Microsoft 365 Copilot embedding trusted intelligence within enterprise workflows

LONDON, 08 July 2026 – GlobalData Plc, the intelligence and productivity platform, today announced the integration of GlobalData’s AI research analyst, Ava, into Microsoft 365 Copilot (Copilot). The integration enables enterprise users to call on Ava directly from within Copilot to retrieve trusted market and company intelligence grounded in GlobalData’s proprietary content ecosystem. Jonathan Hardinges, […]
Read more

UNICORN pact with Japan to enhance India’s warship communications resilience and interoperability, says GlobalData

India and Japan have signed a pact related to the Unified Complex Radio Antenna (UNICORN) project, a next-generation naval communications system designed to provide warships with secure and reliable communications. If executed with disciplined integration timelines and fleet-wide standardization, the acquisition could strengthen survivable command and control, improve operational tempo, and enhance interoperability during joint […]
Read more

FDA-awarded RMAT designations continue to surge in 2025, reveals GlobalData

Since the FDA first awarded a regenerative medicine advanced therapeutic (RMAT) designation in 2017, activity in this space remained relatively modest until 2023. However, the number of RMAT designations increased sharply in 2024, reaching a record of 48 RMAT designations in 2025, reflecting the expanding regenerative medicine landscape and suggesting that a larger number of […]
Read more

AI infrastructure buildout drives massive market cap divergence in APAC during Q2 2026, reveals GlobalData

Asia-Pacific’s (APAC) second quarter (Q2) 2026 market capital table tells one dominant story: the AI infrastructure buildout has become the region’s single biggest wealth-creation and wealth-destruction engine, splitting winners and losers along lines that have little to do with traditional sector logic, according to GlobalData, a leading intelligence and productivity platform. The memory supercycle SK […]
Read more

Europe–US new drug manufacturing outsourcing gap widens, reveals GlobalData

Contract manufacturing facilities located in the US and Europe provide biopharma companies with strategic options to diversify supply chains, access specialized technologies, and speed time-to-market for new drugs. Outsourced dose manufacturing for innovator drugs and biosimilars approved in the US and Europe (the EU and UK) has traditionally oscillated between the two geographies, but there […]
Read more

Commercial insurers face volatility as impending UK leadership shift triggers SME uncertainty, reveals GlobalData

Andy Burnham’s impending takeover from Sir Keir Starmer as UK Prime Minister introduces a wave of political ambiguity that could destabilize commercial insurers. Little is known about any changes Burnham will make that could impact insurance at this point. However, uncertainty is always a concern for SMEs in the UK, which could trouble commercial insurers […]
Read more

Global bank valuations rise in Q2 2026 as capital returns, rate expectations, and Europe’s revival reshape pricing, reveals GlobalData

The global banking sector delivered a markedly different market-cap ranking by the end of the second quarter of 2026 (Q2), as investors rewarded banks that combined resilient earnings, generous capital returns, and stronger investment banking activity. While the largest US banks retained their dominance, European lenders emerged as some of the biggest winners, Japanese banks […]
Read more

MSCopilot Detect emerges as early contender for scalable remote MS monitoring, says GlobalData

Digital biomarkers are gaining momentum in multiple sclerosis (MS) care, with new findings highlighting the potential of smartphone-based assessments to transform disability monitoring. Early evidence supporting MSCopilot Detect use underscores growing industry efforts to enable scalable, remote, and standardized disease assessment, a shift that could reshape clinical  patient monitoring, and the evaluation of MS disease […]
Read more

Real-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData

As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on patient-reported outcomes to carve out space for Briumvi (ublituximab) in a crowded anti-CD20 monoclonal antibody (mAb) field. There is growing importance on patient-centered outcomes as manufacturers seek competitive advantage beyond comparable clinical efficacy in MS treatment, […]
Read more

Produodopa’s positive RWE for Parkinson’s disease to boost clinician confidence in crowded levodopa market, says GlobalData

At the European Academy of Neurology (EAN) 2026 virtual congress, AbbVie presented new 12-month interim data from the ROSSINI study, supporting the real-world safety and effectiveness of Produodopa in patients with advanced Parkinson’s disease. Sustained improvements were observed across motor fluctuations, non-motor symptoms, and selected quality-of-life outcomes. Positive real-world evidence (RWE) for Produodopa could boost […]
Read more

Solar and storage hybrid projects to dominate India’s renewable auctions in 2027–30, says GlobalData

India is rapidly embracing hybrid renewable power, combining solar PV and storage, as the next big wave in its clean energy strategy. With utility tenders increasingly bundling generation and battery storage, the period 2027–2030 is shaping up to be transformational for both project design and investment flows, according to GlobalData, a leading intelligence and productivity […]
Read more

AI coding hiring gains momentum as industries scale real-world use cases, reveals GlobalData

AI coding is revolutionizing software engineering by integrating AI and agentic workflows throughout the development lifecycle. Organizations across industries are increasingly hiring professionals to implement AI coding tools for tasks like code reviews, automated testing, documentation generation, and governance. This shift accelerates software delivery while ensuring consistency, security, and compliance, ultimately leading to higher-quality outputs […]
Read more

India venture capital activity drops amid investor caution and smaller deal sizes, reveals GlobalData

India’s venture capital (VC) market experienced a slowdown from January to May 2026, with deal volume and funding value dropping roughly 9% and 6% year-on-year (YoY), respectively. This decline reflects a more cautious investment landscape characterized by a reduced frequency of big-ticket financing rounds and a shift toward smaller deal sizes, according to GlobalData, a […]
Read more
1 … 6 7 8 9 10 … 777